Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,089 JPY | -0.02% | +0.49% | +0.86% |
04-26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
04-26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 4,219.00 | 4,482.00 | 4,860.00 |
Spread/Res. | -3.08% | -8.77% | -15.86% |
Spread/Supp. | +0.79% | +4.07% | +2.35% |
Support | 4,057.00 | 3,929.00 | 3,995.00 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 4502 Stock
- Charts Takeda Pharmaceutical Company Limited